Navigation Links
$29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation

New York, NY July 14, 2009 NYU and NYU School of Medicine received a $29.4 million, five-year Clinical and Translational Science Award from the National Institutes of Health (NIH) to establish a University-wide Clinical & Translational Science Institute (CTSI) in partnership with the New York City Health and Hospitals Corporation (HHC). The funding is designed to train medical researchers, more rapidly advance science from the lab to the patient to the community and to allow researchers to explore mechanisms of health disparities and develop evidence-based approaches targeted at their reduction. With this grant, NYU, the NYU School of Medicine and HHC will become part of a network of 46 existing Clinical and Translational Science centers based at academic medical centers around the country.

"Our CTSI is truly innovative and will play a critical role in our shared goal of transforming medical research and reducing healthcare disparities in New York City and beyond," said Robert I. Grossman, MD, dean and CEO of NYU Langone Medical Center. "This grant recognizes the extraordinary researchers and scientists at NYU and its School of Medicine and builds upon the historical partnership which brought together the academic excellence of our institutions and the clinical expertise and diversity of HHC."

"NYU School of Medical and HHC have come together to establish the CTSI for the purpose of redefining clinical research through enhanced collaborations of research and clinical teams," said Alan D. Aviles, president of NYC Health and Hospitals Corporation. "Together our institutions have set a course to foster innovation through our joint clinical and translational research and in the process to bring cutting-edge healthcare services to our patients and communities."

Collaborators from clinical and basic science departments throughout the Medical Center and the Colleges and Schools of NYU are strengthening their alliance with eight HHC facilities to address the health problems facing New York and the nation in the 21st century. In addition to NYU School of Medicine, this collaborative effort will bring together the interests and talents of researchers among NYU's active health-related and clinical schools including the School of Dentistry, College of Nursing, Wagner School of Public Service, Steinhardt School of Culture, Education, and Human Development, the Stern School of Business, the Silver School of Social Work, the Courant Institute for Applied Mathematics and the Graduate School of Arts and Sciences to bear on the pressing problems facing New Yorkers.

Robert Berne, NYU's senior vice president for health, said, "This grant is not only a great achievement in and of itself, it is also another demonstration of the more than century-long successful affiliation with HHC and our sustained and successful drive for excellence at the School of Medicine and throughout NYU: excellence in research, in clinical practice, in education, and in leadership."

The CTSI will be directed by Bruce N. Cronstein, MD, the Dr. Paul R. Esserman Professor of Medicine, professor of pathology and pharmacology, NYU School of Medicine, and co-directed by Judith Hochman, MD, the Harold Snyder Family Professor of Cardiology, NYU School of Medicine.

NYU Provost David McLaughlin said, "When scholars of distinction from different disciplines collaborate, the basic, applied, and translational research possibilities are powerful. That is why this grant is so impressive and such a source of pride for the University: it recognizes our researchers' talent, collaborative imagination, and entrepreneurial spirit."

The NYU-HHC CTSI will focus on three primary objectives:

  • Leveraging the individual expertise and ongoing collaboration of NYU Langone Medical Center and HHC researchers to facilitate discoveries in the laboratory that can be moved quickly to the bedside and into the community.

  • Supporting education, training and development of researchers who can conduct the investigations necessary to bring scientific advances to the public. Through the CTSI, established mentors will provide side-by-side partnerships with promising investigators, and training programs have been created to provide doctors with a strong foundation in basic research. Additionally, new scholarships have been created to assist aspiring scientists and physicians in receiving a Master of Science in Clinical Investigation.

  • Enhancing ties between NYU-HHC researchers and the community to more rapidly identify health problems and apply the knowledge gained to promote the use of new developments and evidence-based medicine within communities, thereby reducing healthcare disparities.

Eight of HHC's 11 facilities will participate in the initiative including: The South Manhattan Network (comprised of Bellevue, Metropolitan, Gouverneur and Coler-Goldwater), Woodhull, Coney Island, Kings County and Lincoln hospitals.

"I was proud to support New York University and the NYU School of Medicine's application for this CTSA award from the National Institutes of Health to advance medical research to help reduce medical disparities. What's particularly gratifying to me is the partnership between NYU and the City's Health and Hospitals Corporation, utilizing HHC's expertise and diverse populations at its eight participating facilities," Congresswoman Carolyn Maloney said. "This kind of collaboration is, in a way, the very future of health science."

"The CTSI is a very welcome addition to our medical research and treatment resources," said New York City Council Member Dan Garodnick, who represents the NYU School of Medicine in the Council. "By helping researchers reduce disparities in health care across diverse communities, the CTSI will allow us to make important progress in improving the health of all New Yorkers. I look forward to the work that will result from this valuable collaboration."

"This collaboration between HHC and NYU will bring together each partner's expertise and strengths to create a dynamic center and deliver improved healthcare therapies to our community," said Assemblymember Brian Kavanagh, who represents both NYU Langone Medical Center and Bellevue Hospital Center. "This new facility is a major step forward for our neighborhood and I look forward to continuing to support its progress."


Contact: Lisa Greiner
NYU Langone Medical Center / New York University School of Medicine

Related biology news :

1. Structure of 450 million year old protein reveals evolutions steps
2. First orchid fossil puts showy blooms at some 80 million years old
3. SyntheMed Completes $2.8 Million Equity Financing
4. Rutgers Genetics receives $7.8 million for autism research
5. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
6. UD leads $5.3-million research project on rice epigenetics
7. Rutgers high school outreach gets $3 million boost from NSF
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. UD leads $5.3-million research project on rice epigenetics
10. $22 million gift from Alfred Taubman launches new biomedical research institute
11. Nanobiosym awarded $2 million DTRA contract
Post Your Comments:
(Date:11/19/2015)...  Although some 350 companies are actively involved in ... companies, according to Kalorama Information. These include Roche Diagnostics, Hologic, ... share of the 6.1 billion-dollar molecular testing market, according ... Molecular Diagnostic s .    ... by one company and only a handful of companies ...
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... ... 24, 2015 , ... International Society for Pharmaceutical Engineering (ISPE) ... annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place in ... largest number of attendees in more than a decade. , “The 2015 ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology: